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Abstract
Background: The adipokine leptin realizes signal transduction via four different membrane-anchored leptin receptor (Ob-R)
isoforms in humans. However, the amount of functionally active Ob-R is affected by constitutive shedding of the
extracellular domain via a so far unknown mechanism. The product of the cleavage process the so-called soluble leptin
receptor (sOb-R) is the main binding protein for leptin in human blood and modulates its bioavailability. sOb-R levels are
differentially regulated in metabolic disorders like type 1 diabetes mellitus or obesity and can, therefore, enhance or reduce
leptin sensitivity.
Methodology/Principal Findings: To describe mechanisms of Ob-R cleavage and to investigate the functional significance
of differential sOb-R levels we established a model of HEK293 cells transiently transfected with different human Ob-R
isoforms. Using siRNA knockdown experiments we identified ADAM10 (A Disintegrin And Metalloproteinase 10) as a major
protease for constitutive and activated Ob-R cleavage. Additionally, the induction of lipotoxicity and apoptosis led to
enhanced shedding shown by increased levels of the soluble leptin receptor (sOb-R) in cell supernatants. Conversely, high
leptin concentrations and ER stress reduced sOb-R levels. Decreased amounts of sOb-R due to ER stress were accompanied
by impaired leptin signaling and reduced leptin binding.
Conclusions: Lipotoxicity and apoptosis increased Ob-R cleavage via ADAM10-dependent mechanisms. In contrast high
leptin levels and ER stress led to reduced sOb-R levels. While increased sOb-R concentrations seem to directly block leptin
action, reduced amounts of sOb-R may reflect decreased membrane expression of Ob-R. These findings could explain
changes of leptin sensitivity which are associated with variations of serum sOb-R levels in metabolic diseases.
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Introduction
Leptin (Ob), a 16 kDa protein primarily secreted by adipocytes,
regulates energy homeostasis via so called central mechanism in
the brain. Besides its central effects in the brain, a large number of
peripheral actions have been discovered in the last years. Thus,
leptin affects the immune system by influencing CD4+ T-cell
polarization, B-cell homeostasis as well as renal macrophage
infiltration [1–3] and modulates the severity of sepsis [4].
Furthermore, leptin plays a role in the regulation of liver and
skeletal muscle lipid oxidation and glucose metabolism [5–9].
Leptin actions are mediated through the leptin receptor (Ob-R)
that belongs to the class I cytokine receptor family [10]. So far in
humans four different membrane-anchored Ob-R isoforms have
been discovered which have identical extracellular, ligand-binding
and transmembrane domains but differ in the length of the
intracellular domain. Only the long form (Ob-Rfl) has the so called
Box 3 motif with Tyr1141 and is therefore considered to possess full
signaling capacity via the JAK-STAT (Janus kinase-signal
transducer and activator of transcription) pathway [11]. However,
latest findings indicate that short isoforms may be involved in
leptin signaling as well [12]. In addition, the presence of a soluble
receptor form (sOb-R) [13,14] was demonstrated in peripheral
blood that represents the main leptin binding activity [15] and
reflects the density of membrane Ob-R [16]. Previous findings
suggest a predominant inhibitory effect of sOb-R on leptin
bioactivity in cell and animal models [17,18]. Thus, high sOb-R
concentrations neutralized leptin-mediated STAT3 signaling and
anorexic responses in rats [19] and protected mice against
experimentally-induced sepsis [4]. Interestingly, transgenic mice
with an overexpression of sOb-R showed decreased body weight
and increased energy expenditure which would point to a positive
correlation between serum sOb-R concentrations and leptin
sensitivity [20]. Clinical studies demonstrated both increased and
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the patient. A lack of substrates like glucose in the cellular energy
stores as shown in newly manifested type 1 diabetes mellitus
(T1DM) or anorexia nervosa is associated with an up to a 100-fold
molar excess of sOb-R over leptin in blood [21,22]. In newly
manifested T1DM, lipotoxic effects by elevated levels of free fatty
acid (FFA) may finally cause tissue specific cell death through
apoptosis [23–26] and could be of general importance for the
shedding process. In contrast, excess of substrates like glucose in
the energy stores, as in obesity, was associated with diminished
serum levels of sOb-R. In addition, a strong inverse correlation
between plasma sOb-R levels and the risk of developing type 2
diabetes mellitus in human patients points to an important role of
sOb-R as modulator of leptin action [16,27–29]. Although having
increased leptin concentrations many of obese patients are
resistant to leptin action. Ob-R downregulation besides other
factors like suppressor of cytokine signaling 3 (SOCS3) and
protein-tyrosine phosphatase 1B (PTP1B), could be involved in the
pathogenesis of leptin resistance [30–33]. However, the molecular
mechanisms for receptor downregulation remain completely
unclear. Endoplasmic reticulum (ER) stress is a recently identified
key mechanism for the development of obesity and leptin
resistance [34–36] and therefore could be a trigger for Ob-R
downregulation and suppressed sOb-R generation. The aim of this
work was to investigate regulatory mechanisms of increased and
suppressed generation of sOb-R in a cell model and to elucidate
proteases which process the extracellular Ob-R domain. By
employing specific inhibitors and siRNA technique we demon-
strate the involvement of ADAM10 and even though to a minor
degree of ADAM17 in constitutive and activated Ob-R shedding.
Moreover we reveal that apoptosis and lipotoxicity induce
processing of the extracellular Ob-R domain. In addition, we
show that ER stress and high but still physiological leptin
concentrations decrease sOb-R concentration in the cell superna-
tant. These data present new insights into regulatory mechanisms
of sOb-R generation and add new knowledge to the concept of
leptin resistance.
Materials and Methods
Phorbol myristate acetate (PMA), N-[(2R)-2-(hydroxamidocar-
bonylmethyl)-4-methylpentano-yl]-L-tryptophan methylamide
(GM6001), staurosporine and Z-VAD(OMe)-FMK were pur-
chased from Calbiochem (Merck, Darmstadt, Germany). Fetal
bovine serum and PBS were purchased from Biochrom (Bio-
chrom, Berlin, Germany). DMEM/F12, Opti-MEM, penicillin
and streptomycin, glutamine as well as Lipofectamine 2000 and
Lipofectamine RNAiMAX were purchased from Invitrogen
(Invitrogen by Life Technologies, Darmstadt, Germany). Dimethyl
sulfoxide, sodium palmitate, –oleate, bovine serum albumin and
fatty acid free bovine serum albumin (BSA) were purchased from
Sigma Aldrich (Sigma Aldrich, Munich, Germany). Metallopro-
tease inhibitors GI254023X (GI) and GW280264X (GW) were
kindly provided by Dr. JD Becherer (GlaxoSmithKline, Research
Triangle Park, North Carolina 27709, USA). CCK8-Assay for
determination of cell viability was purchased from Dojindo
Laboratories (Dojindo Laboratories, Munich, Germany).
Plasmid construction
cDNA plasmids for the human short Ob-R isoforms were
generated by subcloning of the unique parts of the respective
isoforms into pcDNA 3.1(+)/ObRfl (kindly provided by Prof. Ross
University of Sheffield, UK). Furthermore we subcloned the
cDNA for Ob-Rfl and Ob-R219.3 into pcDNA3.1 Zeo-myc to
obtain Ob-R constructs myc-tagged at the N-terminus. Sequence
integrity of the constructs was verified by restriction endonuclease
digestion and sequencing. The myc-tagged constructs were used
for all experiments except the investigations on the substrates for
Ob-R shedding and the influence of leptin on constitutive
shedding. Detailed information concerning the cloning of the
different constructs is available on request.
Cells culture and transient siRNA or plasmid transfection
Human embryonic kidney (HEK) 293 cells (American Type
Culture Collection (ATCC) Number: CRL-1573) were cultured in
DMEM/F12 supplemented with 10% fetal bovine serum, 100 U/
ml penicillin, 100 mg/ml streptomycin and 2 mM glutamine. One
day before transient transfection HEK293 cells were seeded into 6-
well or 12-well plates in a density of 0.3610
6 cells or 0.15610
6
cells/well respectively. For siRNA experiments cells were seeded in
a density of 0.2610
6 cells/6-well. On the day of transfection
DMEM/F12 medium was replaced with Opti-MEM and
HEK293 cells were transfected with Ob-R plasmids (1 mg) or
siRNA (50 nM) using Lipofectamine 2000 or Lipofectamine
RNAiMAX, according to the manufacturer’s instructions.
24 hours after siRNA transfection the cells were transfected with
the respective Ob-R constructs using Lipofectamine 2000.
Stimulation experiments with the indicated substances were
carried out in DMEM/F12 medium containing 100 U/ml
penicillin, 100 mg/ml streptomycin and 2 mM glutamine, 0,1%
BSA or 2% BSA (fatty acid free) for palmitate and oleate
incubations. To exclude a possible influence of the solvent of the
used substances controls were performed as indicated.
RNA Isolation and Reverse Transcription
After aspirating the medium, total RNA from transiently
transfected cells was isolated using TRIZOL Reagent (Invitrogen)
according to the instructions of the manufacturer. Quality of the
isolated RNA was confirmed by spectrophotometric measurement
at 260 nm and 280 nm (ND 1000, Nano Drop Products,
Wilmington, DE) and through gel electrophoresis. 2 mg of RNA
were used for first strand DNA-synthesis using SuperScript II
(Invitrogen) following the manufacturer’s instruction. cDNA was
diluted 1:10 in Tris-EDTA-buffer and kept at 220 C until use.
Primer, probes and siRNA
Primers (Eurofins MWG Operon, Ebersberg, Germany) were
choosen to selectively amplify cDNA and to avoid amplification of
genomic DNA traces. ADAM10 (Gen-Bank NM_001110):
forward: 59-CAAAGTCTGAGAAGTGTCGGG-39, reverse: 59-
CTGCACATTGCCCATTAATG-39, anneal-ing temperature
60uC, ADAM17 (GenBank NM_003183): forward: 59-GAG-
GAAAGGAAA GCCCTGTACAGTAG-39, reverse: 59-CA-
GCTGGTCAATGAAATCCCAA-39, annealing temperature
60uC, b-actin (GenBank NM_001101): forward: 59-CCT-
GGCACCCAGCACAAT-39, reverse: 59-GCCGATCCACACG-
GAGTACTT-39, annealing temperature 60uC. The applied
fluorescent probes (Eurofins MWG Operon, Ebersberg, Germany)
lie across an exon-exon boundary to further improve specificity of
the product detection. Sequences were as follows: ADAM17: 59-
TTGTGACATGAATGGCAAATGTGAGAAACG-39, b-actin:
59-ATCA AGATCATTGCTCCTCCT GAGCGCA-39. The
following siRNAs specific for ADAM10 (Stealth Select RNAi
HSS100167) or ADAM17 (Stealth Select RNAi HSS110436) were
used in the present investigation and purchased from Invitrogen.
The applied non-targeting siRNA (ON-TARGETplus, D-001810-
01-20) was purchased from Dharmacon (Dharmacon, Lafayette,
CO).
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For detection of ADAM10 mRNA expression we used SYBR
Green I intercalating dye and for ADAM17 and b-actin mRNA
expression TaqMan quantitative real-time PCR. 2.5 ml of the
respective cDNA were amplified with the AmpliTaq Gold
GeneAmp 5000 10 x PCR Buffer II & MgCl2 Solution Kit or
the Power SYBR Green Master Mix (Applied Biosystems by Life
Technologies, Darmstadt, Germany). The following experimental
protocol was applied for both SYBR Green I and TaqMan assays.
PCR reaction (40 cycles) was performed on an ABI Prism 7900HT
Sequence Detection System (Applied Biosystems): initial denatur-
ation for 10 minutes at 95uC, followed by 40 amplification cycles
at 95uC (15 seconds), annealing at 60uC (1 min). To confirm
product specificity melting curves were performed to verify that
only the specific product was synthesized and to exclude the
formation of primer dimers. The specificity of the PCR was further
verified by subjecting the amplification products to agarose gel
electrophoresis. Plasmids containing ADAM10, ADAM17 or b-
actin were applied to produce standard curves which were used to
calculate the exact copy number of each mRNA. Therefore the
plasmid DNA was diluted in 10-fold serial dilutions (10
7–10
2
copies) and amplified along with cDNA samples. The copy
numbers of the specific target genes were normalized to 10
6 copies
of the housekeeping gene b-actin.
Immunodetection
After incubation with the respective substances the transfected
cells were washed twice with PBS and were lysed in the respective
lysis buffer. Equal amounts of protein were subjected to SDS-
PAGE under reducing (cleaved caspase-3, cleaved PARP,
ADAM10, pSTAT3, PDI, CHOP and BiP) or non reducing
(ADAM17) conditions using Tris-Glycine gels (7.5–15%). The
proteins were then transferred onto PVDF (Polyvinylidene
Fluoride) (ADAM10 and ADAM17) or nitrocellulose membranes
(cleaved caspase-3, cleaved PARP, pSTAT3, PDI, CHOP and
BiP). After the transfer the membranes were blocked in 5% non-fat
dried milk powder in PBS, 0.3% Tween20 and 0.05% Triton X-
100 and further incubated with the respective primary antibody
(1:1,000–3,000) in PBS containing 1–5% (w/v) non-fat dried milk
powder or 5% (w/v) BSA, 0.3% Tween and 0.05 % Triton X-100
at 4uC overnight. Anti-cleaved caspase-3, anti-cleaved PARP, anti-
BiP, anti-PDI (Cell Signaling Technology, New England Biolabs,
Frankfurt, Germany), anti-CHOP (Santa Cruz Biotechnology,
Heidelberg, Germany), anti-ADAM10 (Sigma Aldrich, Munich,
Germany), anti-ADAM17 (R&D Systems, Minneapolis, MN) and
anti-GAPDH (Fitzgerald, Concord, MA) were used as primary
antibodies. For detection of P-STAT3 and total STAT3 PathScan
P-STAT3 (Tyr705), PathScan total STAT3 ELISA (Cell Signaling
Technology) and PhosphoPlus STAT3 (Tyr705) Antibody Kit
were used according to the manufacturer’s instructions.
125I-leptin binding assay
The culture medium was aspirated and the cells were incubated
in 1 ml Krebs-Ringer buffer supplemented with 0.5% BSA (w/v)
per 6-well for 30 min at 37uC and 5% CO2. Subsequently 0.5 kBq
leptin tracer (Mediagnost, Reutlingen, Germany) were added per
well and the cells were incubated for 1 h at 37uC and 5% CO2 in
the presence or absence of 3 mg/ml unlabeled leptin. Cells were
washed twice with PBS/0.5% BSA (w/v) and lysed with 1 ml
0.1 M NaOH solution. Activity in the cell lysates was determined
by gamma counter measurements (Berthold LB2111, Berthold
Technologies, Bad Wildbad, Germany). Specific binding was
determined by subtracting the radioactivity bound in the presence
of 3 mg/ml unlabeled leptin (nonspecific binding) from the
radioactivity bound in the absence of 3 mg/ml unlabeled leptin.
Detection of sOb-R
sOb-R in the supernatant of transfected cells was detected with
an in-house immunofunctional assay as described previously [15].
The in-house immunofunctional assay was also used for
determination of Ob-R protein expression in whole cell lysates.
The cell lysates were diluted 1:5 in PBS before they were applied
in the assay.
Statistical analysis
Data are presented as means 6 SD. For statistical analysis, we
used the STATISTICA 6.0 software program. In the case of non-
normally distributed data, non-parametric statistical tests were
used for all statistical analyses. Otherwise parametric tests were
applied. A P-value ,0.05, was considered statistically significant.
Results
Constitutive Ob-R shedding and mediating proteases
Human membrane-anchored Ob-R isoforms are
substrates for constitutive Ob-R cleavage. Although it is
known that sOb-R is generated through cleavage of membrane-
anchored receptors, is it not yet clear which isoforms serve as
substrate and which protease(s) mediate(s) the cleavage process. So
we transfected HEK cells with the long (Ob-Rfl) or one of the
three short Ob-R isoforms (Ob-R 219.1, Ob-R 219.2 and Ob-R
219.3) to determine if sOb-R is constitutively generated from these
four receptor isoforms. After 48 h incubation at 5% CO2 and
37uC the cell supernatants were collected. Fig. 1A shows that all
isoforms could serve as substrate for the shedding process.
125I-
leptin binding assays and determination of Ob-R protein
expression in whole cell lysates were performed as expression
and functionality control for the different Ob-R isoforms. Fig. 1 B
and C illustrate that short Ob-R isoforms 219.2 and 219.3 showed
the highest Ob-R protein-expression in whole cell lysates as well as
the highest leptin binding. When the amount of generated sOb-R
was normalized to the membrane expression of the respective
isoform, determined by
125I-leptin binding, there was a trend for
an inverse correlation between the length of the cytoplasmic
domain and the amount of shed Ob-R (Fig. 1 D). Similar results
were obtained through normalization of sOb-R to Ob-R protein
in whole cell lysates of HEK cells transfected with the respective
Ob-R isoforms (Supporting information Fig. S1). Ob-Rfl was
demonstrated to be the main signal-transducing isoform [11] and
Ob-R219.3 showed the highest shedding rate in our in-vitro
experiments. Therefore, we focused further investigations in the
present study on these two Ob-R-isoforms.
ADAM10 predominantly mediates constitutive Ob-R
shedding. The possible involvement of metalloproteases in
constitutive Ob-R shedding was investigated by use of the broad
spectrum metalloprotease inhibitor GM6001. The incubation of
Ob-R219.3 transfected cells with GM6001 (25–100 mM) for 24 h
and 48 h (Supporting information Fig. S2) decreased shedding by
up to 52% (P,0.01). Metalloproteases ADAM10 and ADAM17
are probably the best characterized members of the ADAM family
and they are known to catalyze shedding of membrane proteins
which show structural similarities to Ob-R such as the interleukin
15 receptor alpha (IL-15Ra), the interleukin 6 receptor (IL-6R)
and the growth hormone receptor [37–39]. To investigate the
effect of ADAM10 and ADAM17 on Ob-R shedding, Ob-R219.3
transfected HEK cells were incubated with either one of two
metalloprotease inhibitors: GI254023X (GI) that blocks ADAM10
Regulatory Mechanisms for sOb-R Generation
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proteases or GW280264X (GW) that blocks both ADAM10 and
ADAM17 with comparable IC50 values [40,41]. Fig. 2 A reveals
that GI diminished constitutive shedding by 53% (P,0.01)
whereas incubation with GW resulted in 52% (P,0.01)
decreased sOb-R levels. To further verify to which extent the
different ADAMs participate in Ob-R cleavage of the two selected
isoforms, we next performed ADAM10 and ADAM17 siRNA
knockdown experiments. HEK cells were first transfected with an
ADAM10 or ADAM17 specific siRNA or a non-targeting siRNA.
24 hours later the siRNA transfected cells were transfected with
Ob-Rfl or Ob-R219.3. Quantitative RT-PCR measurements
revealed a knockdown of ADAM10 or ADAM17 mRNA
expression of at least 60% (P,0.001) 24 h–72 h post
transfection (Fig. 2 B). The observed mRNA knockdown was
paralleled by a decrease in ADAM10 and ADAM17 protein levels
(Fig. 2 C). ADAM10 knockdown sufficiently blocked the
constitutive release of sOb-R into the supernatant of Ob-Rfl
transfected cells by up to 57% (Fig. 2 D, P,0.001) whereas
ADAM17 knockdown less effectively diminished sOb-R levels up
to 30% (P,0.01). The release of sOb-R by Ob-R219.3 transfected
cells was decreased with a maximum of 64% (Fig. 2 E P,0.001)
after ADAM10 but only up to 39% (P,0.01) by ADAM17
siRNA-mediated knockdown (Fig. 2 E).
Induction of Ob-R shedding
PKC stimulation increases Ob-R shedding. It is known
that metalloprotease-mediated shedding processes can be induced
by activation of PKC [42]. Hence we transfected HEK cells
transiently with Ob-Rfl or Ob-R219.3 and stimulated these cells
with the PKC-activator PMA (10 ng/ml) for 24 h. The incubation
resulted in a 3.98-fold (P,0.01)/4.14-fold (P,0.001) increase of
sOb-R in the cell supernatant (Fig. 3 A). Co-incubation of Ob-
R219.3 transfected cells with the protein kinase inhibitor
staurosporine (0.01 mM) inhibited the PMA stimulated increase
of sOb-R concentration after 24 h by 60% (P,0.05) (Fig. 3 B).
PKC-induced Ob-R shedding is mediated by ADAM10 and
to a minor degree by ADAM17. To elucidate the importance
of ADAM10 and ADAM17 for PKC-induced Ob-R shedding,
Ob-R219.3 transfected cells were incubated with the specific
ADAM10 or ADAM10/17 inhibitors GI and GW for 24 h.
Results shown in supporting information Fig. S3 reveal that GI
diminished PMA-induced shedding by 48% (P,0.01) and that
GW-mediated decrease was 51% (P,0.01). To clarify the effect of
either ADAM on PKC-induced Ob-R shedding, we knocked
down ADAM10 and ADAM17 in Ob-Rfl or Ob-R219.3
transfected HEK cells. PMA-induced shedding of Ob-Rfl
transfected cells was only decreased by up to 20% (P,0.05)
independently of the siRNA applied (Fig. 3 C). However
simultaneous knockdown of ADAM10 and ADAM17 led to a
significant decrease of 43% (P,0.01) supporting that both
ADAMs participate in PKC-induced shedding of Ob-Rfl. PMA-
induced elevation of sOb-R in the supernatant of Ob-R219.3
transfected cells was dimished by 52% (P,0.01) after knocking
down ADAM10 (Fig. 3 D) compared to the sample treated with
non-targeting siRNA. Knockdown of ADAM17 only decreased
sOb-R concentration by 24% (P,0.001).
Caspase-mediated apoptosis increases Ob-R shedding
dependent on ADAM10 expression. Staurosporine, beside its
inhibitory effect on protein kinases is known to be an effective
inducer of apoptosis. To investigate a potential association
between apoptosis and Ob-R shedding we incubated Ob-R219.3
Figure 1. Constitutive shedding of human Ob-R isoforms. (A) sOb-R concentration in the supernatant of Ob-R transfected HEK cells after
incubation for 48 h under normal culture conditions (37uC, 5% CO2). VC, vector control (pcDNA 3.1) (B) Ob-R in whole cell lysates of Ob-R transfected
HEK cells was determined by an in-house immunofunctional assay. Ob-R protein expression is presented realtive to Ob-R levels of Ob-Rfl transfected
cells. (C) I
125-leptin binding of Ob-R transfected HEK cells. Ob-R transfected cells were incubated for 48 h under normal culture conditions (37uC,
5% CO2) and I
125-leptin binding assay was performed. I
125-leptin binding is shown in % relative to amount of used I
125-leptin tracer. (D) Normalisation
of sOb-R (A) to I
125-leptin binding (C). Data are presented as means 6 SD of n$3 experiments; n.d., not detectable.
doi:10.1371/journal.pone.0034787.g001
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48 h. This resulted in up to 2.31-fold (P,0.01) increased sOb-R
levels compared to the non-treated control (Fig. 4 A) after 48 h.
When investigating the long isoform Ob-Rfl the level of sOb-R
remained comparable to control data (Fig. 4 A). Western blots for
cleaved caspase-3 and cleaved Poly-(ADP-ribose) Polymerase
(PARP) (Fig. 4C) and ELISA measurements of nucleosome
release into the cytoplasm (Supporting information Fig. S4)
proved successful induction of apoptosis by 0.5 mM
staurosporine after 48 h. Pre-incubation with broad spectrum
caspase inhibitor Z-VAD(OMe)-FMK(100 mM) impaired
induction of apoptosis and diminished staurosporine-mediated
Figure 2. Constitutive shedding of human Ob-R isoforms is mainly mediated by ADAM10. (A) sOb-R levels in the supernatant of Ob-
R219.3 transfected HEK cells after incubation with the metalloprotease inhibitors GI/GW (3 mM) or DMSO (0.1%) for 24 h. sOb-R levels of GI/GW
incubated cells are presented relative to those of cells incubated with DMSO. (B and C) ADAM10 and ADAM17 mRNA (B) and protein expression (C) in
lysates of HEK cells transfected with a specific siRNA for ADAM10 or ADAM17 or a non-targeting siRNA (50 nM). (D and E) sOb-R levels in the
supernatant of HEK cells transfected with a specific siRNA for ADAM10, ADAM17 or a non-targeting siRNA (50 nM) and subsequently with Ob-Rfl (D)
or Ob-R219.3 (E) followed by a further incubation under normal culture conditions for 24–72 h. sOb-R levels of ADAM10/ADAM17 siRNA transfected
cells are shown relative to those of cells transfected with a non-targeting siRNA. Data are presented as means 6 SD of n$3 experiments.
doi:10.1371/journal.pone.0034787.g002
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clarify if ADAM10 and ADAM17 are involved in staurosporine-
induced shedding we knocked down ADAM10 or ADAM17 with
a specific siRNA as described before and incubated Ob-R219.3
transfected cells with staurosporine 0.5 mM for 48 h. Fig. 4D
shows that ADAM10 siRNA knockdown resulted in 84% (P,0.01)
whereas a knockdown of ADAM17 diminished sOb-R levels by
23% (p=0.26) compared to the sample transfected with a non-
targeting siRNA. To elucidate if the effects on sOb-R generation
were staurosporine-specific we incubated Ob-R transfected HEK
cells with doxorubicin (inhibitor of topoisomerase II) as a more
specific inducer of apoptosis. We demonstrated that doxorubicin
increased the amount of shed Ob-R219.3 in a comparable manner
as 0.1 mM Staurosporine, whereas no significant changes could be
determined for Ob-Rfl (Supporting information Fig. S5).
Lipotoxicity and apoptosis induced by the saturated FFA palmitate
increase sOb-R levels. Lipotoxicity caused by elevated free fatty
acids in tissues other than the adipose tissue could finally cause cell
death through apoptosis. So we speculated that free fatty acids
influence Ob-R cleaveage. By incubating Ob-R219.3 or Ob-Rfl
transfected HEK cells with oleate or palmitate (0.5 mM–1 mM)
we could show that palmitate but not oleate increased the amount
of shed Ob-R. Ob-R219.3 transfected cells showed up to 3.5-fold
(P,0.01) and Ob-Rfl transfected cells up to 1.4-fold(P,0.05)
elevated sOb-R levels in the supernatant after 48 h (Fig. 5 A). To
elucidate the role of ADAM10 and ADAM17 in palmitate-
mediated shedding we knocked down ADAM10 or ADAM17 with
a specific siRNA as described before and incubated Ob-R219.3 or
Ob-Rfl transfected cells with palmitate 1 mM for 48 h. Fig. 5 B
displays that knockdown of ADAM10 resulted in up to 81% (Ob-
R219.3, P,0.01) or 87% (Ob-Rfl, P,0.05) decreased amounts of
sOb-R whereas a knockdown of ADAM17 diminished sOb-R
levels by 44% (Ob-R219.3, P,0.05) or 11% (Ob-Rfl, P=0.11)
compared to cells treated with a non-targeting siRNA. The
observed increase was accompanied by decreased cell viability
measured by CCK-8 assay (data not shown) as a consequence of
apoptosis demonstrated through detection of cleaved caspase-3
and cleaved PARP (Fig. 5 C and E). Interestingly a co-incubation
of Ob-R-transfected cells with palmitate 1 mM and broad
spectrum caspase inhibitor Z-VAD(OMe)-FMK (100 mM)
inhibited induction of caspase-3 and PARP-cleavage but did
neither restore cell viability (data not shown) nor decreased sOb-R
to basal levels (Fig. 5 D and E). In contrast co-incubation of Ob-R
transfected cells with palmitate 0.5–1 mM and increasing
concentrations of oleate 0.1–0.5 mM reversed the lipotoxic
effects of palmitate (Fig. 5F–H) and decereased sOb-R
concentration to basal levels (Fig. 5F and G).
Modulation of leptin-mediated STAT3 phosphorylation
by sOb-R and Ob-R isoform 219.3
We elucidated if leptin actions via STAT3 phosphorylation
might be modulated by co-expression of Ob-R219.3. Ob-Rfl and
Figure 3. PKC activation leads to an increased release of sOb-R by Ob-R transfected cells, mainly mediated by ADAM10. (A) sOb-R
levels in the supernatant of Ob-Rfl or Ob-R219.3 transfected cells after incubation with PMA (10 ng/ml) or DMSO (0.1%) for 24 h. sOb-R levels of PMA-
treated cells are displayed relative to sOb-R levels of DMSO-treated cells. (B) sOb-R levels in the supernatant of Ob-R219.3 transfected cells after
incubation with PMA (10 ng/ml) and or staurosporine (0.01 mM) or DMSO (0.1%) for 24 h. sOb-R levels of PMA- and staurosporine-treated cells are
shown relative to those of cells treated with DMSO. (C, D) sOb-R levels in the supernatant of HEK cells transfected with a specific siRNA for ADAM10
and or ADAM 17 or a non-targeting siRNA (50 nM) and subsequently with Ob-Rfl (C) or Ob-R219.3 (D) followed by a further incubation for 24–72 h
with PMA (10 ng/ml). sOb-R levels of ADAM10/ADAM17 siRNA transfected cells are presented relative to sOb-R levels of cells transfected with a non-
targeting siRNA. Data are presented as means 6 SD of n$3 experiments.
doi:10.1371/journal.pone.0034787.g003
Regulatory Mechanisms for sOb-R Generation
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34787Ob-R219.3 or Ob-Rfl and GFP (vector control, equimolar to Ob-
R219.3) co-transfected cells were serum starved for 16 h and
afterwards stimulated with leptin (100 ng/ml) for 30 min. Fig. 6A
illustrates that the co-expression of Ob-Rfl and Ob-R219.3
reduced leptin-induced STAT3 activation by 62.2%
(P,0.01)compared to cells transfected with Ob-Rfl + GFP only.
To clarify the influence of increasing sOb-R levels on leptin
signaling we pre-incubated medium containing 10 ng/ml leptin
with sOb-R (1–1000 ng/ml) for one hour at 37uC. Afterwards the
medium was applied to stimulate 16 h serum-starved HEK cells
for 30 min. Fig. 6 B shows that increasing sOb-R concentrations
reduced leptin-mediated STAT3 phosphorylation compared to
Ob-Rfl transfected cells incubated with medium free of sOb-R. An
effect of 20–94% inhibition was detectable for the addition of 100–
1000 ng/ml sOb-R, whereas total STAT3 levels remained
unchanged.
Figure 4. Caspase-mediated apoptosis, induced by incubation with staurosporine, activates Ob-R shedding mainly mediated by
ADAM10. (A) sOb-R levels in the supernatant of Ob-Rfl or Ob-R219.3 transfected cells after incubation with staurosporine (0.1–0.5 mM) or DMSO
(0.1%) for 24 h and 48 h. sOb-R levels of staurosporine-treated cells are displayed relative to sOb-R levels of cells treated with DMSO (B) sOb-R levels
in the supernatant of Ob-R219.3 transfected cells after pre-incubation with the broad spectrum caspase inhibitor Z-VAD(OMe)FMK (100 mM) or DMSO
(0.1%) for 30 min and subsequent stimulation with staurosporine (0.1–0.5 mM) or DMSO (0.1%) for 24 h and 48 h. sOb-R levels of staurosporine- or Z-
VAD(OMe)FMK-treated cells are shown relative to those of cells treated with DMSO. (C) Representative western blot of cleaved caspase-3 and cleaved
PARP after staurosporine incubation. Ob-R219.3 transfected cells were pre-incubated with Z-VAD(OMe)FMK (100 mM) or DMSO (0.1%) for 30 min and
subsequently stimulated with staurosporine (0.1–0.5 mM) or DMSO (0.1%) for 48 h. Following this incubation cleaved caspase-3 and cleaved PARP in
cell lysates was determined by western blot analysis. PC, positive control (cell lysate of Jurkat cells treated with cytochrome c). (D) sOb-R levels in the
supernatant of HEK cells transfected with a non-targeting, ADAM10 or ADAM17 specific siRNA (50 nM) and subsequently with Ob-R219.3 after
incubation with staurosporine (0.5 mM) or DMSO (0.1%) for 48 h. sOb-R levels of ADAM10 and ADAM17 siRNA transfected cells are presented relative
to sOb-R levels of cells transfected with a non-targeting siRNA and treated with DMSO. Data are presented as means 6 SD of n$3 experiments.
doi:10.1371/journal.pone.0034787.g004
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34787sObR generation is regulated by leptin level and ER stress
Leptin decreases sOb-R concentrations. In adiposity high
leptin levels are correlated with decreased sOb-R levels [27–29].
As such a leptin excess could result in an Ob-R downregulation we
asked, whether this process leads to a decline in the constitutive
generation of sOb-R. Therefore, we incubated Ob-Rfl or Ob-
R219.3 transfected HEK cells for 24 h with 5–100 ng/ml leptin.
Fig. 7 demonstrates that 100 ng/ml leptin decreased the amount
of sOb-R in the cell supernatant by up to 46%(P,0.001) for Ob-
Rfl and up to 39% (P,0.01) for Ob-R219.3. The decrease was
concentration-dependent but independent of the length of the
transfected Ob-R isoform.
ER stress decreases membrane Ob-R expression, impairs
leptin signaling and reduces sOb-R generation. Obesity is a
state of low grade inflammation associated with ER stress. To
investigate whether or not membrane Ob-R expression and leptin
signaling are affected by ER stress we applied tunicamycin, an
inhibitor of protein N-glycosylation. Ob-Rfl transfected cells were
incubatedwithtunicamycinfor4–24 handsubsequentlystimulated
with leptin (100 ng/ml) for 30 min. Cells and cell lysates were
subjected to
125I-leptin binding assay, P- and total STAT3 ELISA
Figure 5. Enhanced release of sOb-R after palmitate incubation is mediated by ADAM10 and ADAM17 and inhibited by oleate. (A)
sOb-R levels in the supernatant of Ob-Rfl or Ob-R219.3 transfected cells after incubation with palmitate (0.5–1 mM), oleate (0.5 mM–1 mM or
methanol (2%) for 24 and or 48 h. sOb-R levels of palmitate- or oleate-treated cells are displayed relative to those of cells treated with methanol. (B)
sOb-R levels in the supernatant of HEK cells transfected with a non-targeting, ADAM10 or ADAM17 specific siRNA (50 nM) and subsequently with Ob-
R219.3, after incubation with palmitate (1 mM) or methanol (2%) for 48 h. sOb-R levels of ADAM10 and ADAM17 siRNA transfected cells are shown
relative to sOb-R levels of cells transfected with a non-targeting siRNA and treated with methanol. (C) Representative western blot of cleaved PARP
after palmitate incubation. Ob-R transfected cells were incubated with palmitate (0.5–1 mM) or Methanol (2%) for 24 and 48 h. Following this
incubation cleaved PARP in cell lysates was determined by western blot analysis. (D) sOb-R levels in the supernatant of Ob-Rfl or Ob-R219.3
transfected cells after incubation with palmitate 1 mM and Z-VAD 100 mM or methanol (2%) for 48 h. sOb-R levels of palmitate- and or Z-VAD-
stimulated cells are displayed relative to those of cells treated with methanol. (E) Representative western blot of cleaved caspase-3 and cleaved PARP.
Ob-R transfected cells were incubated with palmitate (0.5–1 mM), palmitate (0.5–1 mM) and Z-VAD (100 mM) or Methanol (2%) for 48 h. Following
this incubation cleaved caspase-3 and cleaved PARP in cell lysates was determined by western blot analysis. (F and G) sOb-R levels in the supernatant
of Ob-Rfl or Ob-R219.3 transfected cells after incubation with palmitate (1 mM), oleate (0.1–0.5 mM), palmitate (1 mM) and oleate (0.1–0.5 mM) or
methanol (2%) for 48 h. sOb-R levels of palmitate-, oleate– or palmitate- and oleate-treated cells are displayed relative to those of cells treated with
methanol. (H) Representative western blot of cleaved PARP after co-incubation with palmitate and oleate. Ob-R transfected cells were incubated with
palmitate (0.5–1 mM), palmitate (0.5–1 mM) and oleate (0.1–0.5 mM) or Methanol (2 %) for 48 h. Following this incubation cleaved PARP in cell
lysates was determined by western Blot analysis. Data are presented as means 6 SD of n$3 experiments (Fig. 5 D and E, n=2).
doi:10.1371/journal.pone.0034787.g005
Figure 6. Co-expression of Ob-R219.3 to Ob-Rfl and increased sOb-R levels modulate leptin signaling of Ob-Rfl. (A) Ob-R transfected
cells were serum-starved for 16 h and subsequently incubated with leptin (100 ng/ml) for 30 min. P-STAT3 and total STAT3 levels in lysates of HEK
cells transfected with equimolar amounts of Ob-Rfl + GFP (equimolar to Ob-R219.3) or Ob-Rfl + Ob-R219.3 were determined by ELISA and western
blot. P-STAT3/total STAT3 ratios are displayed relative to P-STAT3/total STAT3 ratio of non-treated cells transfected with Ob-Rfl + GFP. (B) P-STAT3 and
total STAT3 levels in lysates of HEK cells transfected with Ob-Rfl. Ob-Rfl-transfected cells were stimulated with media containing leptin (10 ng/ml) and
increasing concentrations of sOb-R (0–1000 ng/ml). P-STAT3 and total STAT3 levels are displayed relative to those of leptin-treated control without
sOb-R. Data are presented as means 6 SD of n$2 experiments.
doi:10.1371/journal.pone.0034787.g006
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didnotchangesignificantlyoverthe24 hoftunicamycinincubation
determinedbyCCK-8assay(datanotshown).Fig.8Aillustratesthe
successful activation of ER-stress markers ‘‘immunoglobulin heavy
chain binding protein’’ (BiP), also referred as 78-kDa glucose-
regulated protein (GRP78) and the C/EBP homology protein
(CHOP). Another marker protein named protein-disulfide-
isomerase (PDI) remained unaffected.
125I-leptin binding assay
revealed a 60% decreased leptin binding after 4 h of tunicamycin
incubation which further declined to 15% of control level after 24 h
(Fig. 8 B). Leptin-induced STAT3 phosphorylation was decreased
by 47% (P,0.01) after 4 h and completely blocked after 12 h
incubation with tunicamycin (Fig. 8 C). Total STAT3 amounts
remained unchanged after tunicamycin treatment (Fig. 8 D). To
elucidate if the reduced membrane Ob-R expression is reflected by
decreased sOb-R levels,we incubated Ob-Rflas wellas Ob-R219.3
transfectedcellswithtunicamycin(3–20 mg/ml)for24–48 h.Fig.8E
showsthattunicamycinincubationledto65%(P,0.001)decreased
sOb-R levels compared to the non-treated sample already after
24 h. The inhibition reached a maximum of 92% and 90% for Ob-
Rfl and Ob-R219.3 after 48 h.
Discussion
In previous studies we and others showed that sOb-R represents
the main leptin binding activity in human blood [15] and
modulates the bioavailability of free leptin [15–19]. Detailed
knowledge about the basic shedding mechanisms of Ob-R is
mandatory to manipulate leptin actions by increasing or
decreasing sOb-R levels in conditions of leptin deficiency or
resistance. In the present study we elucidated regulatory
mechanisms for sOb-R generation covering receptor shedding
and receptor trafficking in HEK cells with a transient overexpres-
sion of different Ob-R isoforms. We evidenced that the four
known human membrane-anchored Ob-R isoforms were sub-
strates for generation of sOb-R with constitutively low levels. The
degree to which each isoform contributes to the pool of serum
sOb-R appeared to correlate with the respective Ob-R total and
membrane protein expression and seemed to be inversely
associated with the length of the cytoplasmic domain. Previously,
Ob-Rfl was demonstrated to be the main signal-transducing
isoform [11] and Ob-R219.3 was shown to be expressed
abundantly in peripheral tissues and displayed the highest
shedding rate in our in-vitro experiments. Therefore, we focused
our investigations in the present study on these two physiologically
relevant Ob-R-splice variants. ADAM10 and or ADAM17 are
known members of the metalloprotease family that cleave
transmembrane receptors like IL-6R, IL-15Ra and the growth
hormone receptor which like Ob-R belong to the class I cytokine
receptor family [37–39]. Downregulation of sOb-R by ADAM10
or ADAM17 inhibitors and through ADAM specific siRNA
knockdown identified ADAM10 as the major protease for
constitutive Ob-R shedding. ADAM17 appeared to be involved
in the constitutive cleavage process only to a minor degree. This
hypothesis was further supported by measurements of sOb-R
levels in serum of ADAM17
ex/ex mice (data not shown) [43].
Serum sOb-R concentrations of these mice did not differ
significantly from those of wild type mice despite of the protease
knockdown. We further clarified mechanisms that induce or
reduce the cleavage of membrane Ob-R. The detected increase of
Ob-R shedding upon PKC activation is in line with previously
published results that showed an activating effect of PKC
stimulation on Ob-R cleavage [13,14]. Interestingly, our data
point to an isoform-dependent differential regulation of the
shedding process: while ADAM10 appears to be responsible for
PMA-induced shedding of Ob-R219.3, Ob-Rfl was shed by
ADAM10 as well as ADAM17 in response to PMA treatment. As
we could not completely inhibit constitutive and PKC-activated
Ob-R shedding by knocking down ADAM10 and ADAM17 in
our cell culture experiments, effects of other proteases cannot be
fully excluded. Recently, Wauman et al. [44] showed that
ADAM10 and ADAM17 were involved in RNF41 induced
shedding of the human long Ob-R isoform and mouse short
Ob-R isoform which confirms our findings that especially these
two ADAM family members play an important role in activated
Ob-R ectodomain-shedding. Additionally, we demonstrated that
apoptosis induced by staurosporine and doxorubicin (Supporting
information Fig. S5) activated shedding from Ob-R219.3 trans-
fected cells. In contrast, the shedding rate of Ob-Rfl transfected
cells remained negligible with both substances. This is interesting
because it is in contrast to PMA incubation which increased
shedding of Ob-Rfl and Ob-R219.3 to approximately the same
extent. These results suggest that the amount of shed Ob-R
depends on the shedding stimulus and the isoform-specific length
of the cytoplasmic domain. Perhaps turnover of Ob-Rfl is greater
than of Ob-R219.3, which would result in a bigger abundance of
the short isoform Ob-R219.3 compared to the long isoform Ob-
Rfl. A similar effect had been described for the human growth
hormone receptor [45]. In addition, the longer intracellular
domain of Ob-Rfl could also have a stabilizing effect and therefore
protects Ob-Rfl from shedding. Differences in shedding efficacy
between the short isoform Ob-R219.3 and the long isoform Ob-
Rfl might be of importance for leptin actions. One supposed
example for the physiological relevance of this process is leptin-
transport across the blood brain barrier which is suggested to be
dependent on the short isoforms [46,47]. The preferential
shedding of short isoforms could restrain this transport leading
to impaired central leptin actions without affecting its peripheral
effects. Moreover, in peripheral tissues with high expression of
short Ob-R isoforms increased shedding could have a dual effect
on leptin signaling via Ob-Rfl. Shedding of preferably short Ob-R
isoforms could make the cells more sensitive to leptin. But with
increasing levels of generated sOb-R an inhibitory effect of the
released Ob-R ectodomain on leptin signaling may prevail. By use
of the broad spectrum caspase inhibitor Z-VAD(OMe)-FMK we
proved that increased shedding due to staurosporine treatment
Figure 7. Leptin inhibits sOb-R release from Ob-Rfl or Ob-
R219.3 transfected cells into the supernatant. Ob-Rfl or Ob-
R219.3 transfected cells were incubated with leptin (5–100 ng/ml) for
24 h. Following this incubation sOb-R in the supernatant was
determined. sOb-R levels of leptin-treated cells are shown relative to
those of non-treated cells. Data are presented as means 6 SD of n$3
experiments.
doi:10.1371/journal.pone.0034787.g007
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caspase inhibitor did not decrease the shedding rate to the basal
level, a participation of caspase-independent mechanisms cannot
be excluded. This hypothesis is further supported by the finding
that staurosporine induces apoptosis via caspase-dependent as well
as -independent ways [48]. Our finding that staurosporine-
induced shedding of Ob-R mainly depends on the activity of
ADAM10 is similar to mechanisms reported for distinct, even
unrelated membrane receptors and proteins such as IL-6R, L-
selectin and L1 [38,49–52]. Therefore, ADAM-mediated cleavage
of membrane proteins as consequence of induced apoptosis
appears to be a general shedding mechanism. Because FFAs,
particularly saturated, long chain fatty acids like palmitate or
stearate, are also known to induce apoptosis [23,24], we speculated
that they could be major players for the induction of shedding as
well. Fatty acid-induced shedding of both Ob-R isoforms that we
observed in our investigations was mediated primarily by
ADAM10 with a minor participation of ADAM17 and activated
only by palmitate but not oleate. The latter difference might be
due to the distinct cellular fate of these fatty acids. Whereas oleate
is used to synthesize triglycerides which are stored without
affecting cell viability [24], excess amounts of palmitate are only
poorly incorporated into triglycerides and cause lipoapoptosis
which in turn could lead to increased Ob-R shedding. Both,
palmitate as well as staurosporine seem to directly influence Ob-R
cleavage since a knockdown of ADAM10– or ADAM17-activity
inhibited staurosporine and palmitate effects on sOb-R concen-
tration. An also imaginable passive increase of Ob-R in the
supernatant through an efflux across leaky membranes or
formation of cell debris from dying cells should not be affected
by the siRNA knockdown. Recently it was shown that mono-
unsaturated fatty acids like oleate could prevent the lipotoxic
effects of saturated fatty acids like palmitate [24]. Our results from
oleate and palmitate co-incubation experiments not only affirm
these findings but also let us speculate that the ratio of saturated to
unsaturated fatty acids may influence the amount of shed Ob-R.
Figure 8. ER stress causes downregulation of membrane Ob-R, impaired leptin signaling via Ob-Rfl and decreased sOb-R
concentrations. (A) Representative western blot for protein expression of ER stress markers BiP (GRP78), CHOP (GADD153) and PDI after treatment
of Ob-R transfected HEK cells with tunicamycin (3 mg/ml) or DMSO (0.1%) for 4–24 h. (B) Ob-Rfl transfected cells were incubated with tunicamycin
(3 mg/ml) or DMSO (0.1%) for 4–24 h and I
125-leptin binding assay was performed. I
125-leptin binding of tunicamycin-treated samples is displayed
relative to that of non-treated controls. (C and D) P-STAT3 (C) and total STAT3 (D) levels in lysates of Ob-Rfl transfected cells after incubation with
tunicamycin (3 mg/ml) or DMSO (0.1%) for 4–24 h and subsequent stimulation with leptin (100 ng/ml) for 30 min. P-STAT3 and total STAT3 levels of
leptin-stimulated cells are displayed relative to that of non-treated controls. (E) sOb-R levels of Ob-Rfl or Ob-R219.3 transfected cells after incubation
with tunicamycin (3–20 mg/ml) or DMSO (0.2%) for 24 and 48 h. sOb-R levels of tunicamycin-treated cells are displayed relative to those of non-
treated cells. Data are presented as means 6 SD of n$3 experiments (Fig. 8 A, n=1; Fig. 8 B, n=2).
doi:10.1371/journal.pone.0034787.g008
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caspase inhibitor Z-VAD(OMe)-FMK reduced sOb-R to basal
level and restored cell viability we suggest that similar to
staurosporine caspase– or even apoptosis-independent mecha-
nisms are of importance for effects seen after palmitate incubation.
Lipotoxicity caused by elevated free fatty acids in tissues other than
the adipose tissue [25,26] and apoptosis for example of pancreatic
beta cells occur during the manifestation of T1DM. Accordingly,
our data suggest that strongly increased sOb-R levels observed in
newly manifested T1DM [21,22] could be induced by high levels
of saturated FFAs like palmitate. Recently, it was demonstrated
that high doses of leptin even without insulin administration
normalize glucose and lipid metabolism in type I diabetic mice
[53–55]. The high doses of leptin applied in these studies might
have been necessary to overcome the inhibitory effect of high sOb-
R levels in the type I diabetic mice. This hypothesis is supported
by our findings that co-incubation of leptin with increasing
amounts of sOb-R resulted in reduced leptin-mediated STAT3
phosphorylation in Ob-Rfl transfected HEK293 cells. Our data
suggest that sOb-R levels which exceed a molar ratio of sOb-R to
leptin of 2:1 exhibit a predominant inhibitory effect on leptin
signaling, a ratio that is frequently observed in catabolic diseases
and early childhood [21,22,56]. As we could show that sOb-R
mainly originates from short Ob-R isoforms, the signal transduc-
ing long Ob-R isoform in the mouse model described before might
still occurred at the cell surface at sufficient amounts to mediate
beneficial effects of the ligand. Therefore, decreasing Ob-R
shedding by use of specific ADAM10 inhibitors perhaps could
further improve the effects of a leptin mono therapy. Moreover,
we demonstrated that co-expression of the short isoform Ob-
R219.3 with Ob-Rfl impaired leptin signalling compared to cells
transfected with Ob-Rfl only. These findings are in contrast to
Bacart et al. [44,57] who demonstrated that increasing amounts of
the co-expressed short isoform Ob-Ra did not alter leptin signaling
of the long receptor variant. However, our findings are supported
by results of White et al. who demonstrated a modest repression on
signaling of wildtype Ob-Rfl when they co-transfected increasing
amounts of a truncated Ob-Rfl isoform [58]. In addition to
modulation of shedding enzyme activity, regulation of Ob-R
supply is a determining factor for the extent of sOb-R generation.
Ligand-receptor interactions as well as receptor trafficking from
ER to membrane could affect the amount of membrane-anchored
Ob-R. Accordingly, we investigated to which extent high leptin
levels and low grade inflammation- associated ER stress – two
markers linked to obesity – take effect on leptin receptor
availability for sOb-R generation. The exposure of Ob-R
transfected cells to leptin concentrations in the physiological range
led to decreased sOb-R levels. Bjorbaek et al. showed that leptin/
leptin-receptor-complexes were internalized and transported to
lysosomes for degradation [59]. This ligand-induced receptor
internalization process probably accounts for the temporarily
decrease of the plasma membrane Ob-R pool, resulting in
decreased sOb-R levels as observed in the present study. The
nucleoside antibiotic tunicamycin inhibits N-glycosylation of
proteins [60] and increases the protein load of the ER finally
leading to ER stress induction. We found a reduced leptin binding
and an impaired up to blunted leptin signaling in Ob-Rfl
transfected cells in parallel to reduced sOb-R levels after
tunicamycin-induced ER stress. These findings support the
hypothesis that increased ER stress may decelerate the turnover
of Ob-R to the plasma membrane. Concomitantly, constitutive
shedding could further decrease the amount of membrane Ob-R
which might foster deterioration of leptin signaling. These
hypotheses could complement recent findings describing a
participation of the NF-kB (nuclear factor ‘kappa-light-chain-
enhancer’ of activated B-cells) as well as the JNK (c-Jun N-
terminal kinase) signaling pathway in the development of ER
stress- and obesity-associated leptin resistance [34–36]. An
increase in PTP1B and SOCS3 protein levels that were reported
previously to be inducers of leptin resistance [11,30–35,61] could
accelerate the process of becoming insensitive to leptin on cellular
level. We suggest that chronic ER stress in obese patients decreases
the amount of sOb-R due to diminished membrane Ob-R
expression. Accordingly, the determination of serum sOb-R
concentrations may serve as a tool to monitor the development
of a leptin resistant state. This suggestion was already supported by
clinical data [16]. Future studies are necessary to clarify the exact
mechanisms for reduced sOb-R concentrations in response to ER
stress and high leptin levels. Such investigations should include the
use of receptor endocytosis inhibitors like cytochalasin and the
determination of ER stress inducing agent-linked effects on
ADAM10 and ADAM17 activity. Since tunicamycin is a synthetic
and not a physiological stimulus of ER stress, continuing
investigations should be extended to animal models of obesity in
order to uncover to which extent ER stress- associated effects on
the leptin – leptin receptor axis are of importance in-vivo.
Our results base upon transient overexpression of Ob-R
isoforms in HEK cells but not upon investigations in primary
cells or non-transfected cell lines. This restriction is hardly to
overcome as for example endogenous Ob-R expression of primary
human hepatocytes or non-transfected HEK cells is to low for the
analytical differentiation. Otherwise the contribution of individual
isoforms to the overall amount of shed Ob-R and isoform-specific
regulation can be only proven by a cell model with receptor
transfection.
In summary, we provide novel insights into the regulatory
mechanisms for sOb-R generation and its importance as a main
player in the regulation and for the monitoring of leptin action:
high sOb-R concentrations seem to directly modulate leptin effects
thereby acting predominantly inhibitory. In contrast, low sOb-R
levels, although having no direct influence on leptin action, could
serve as one potential indicator for the development of a leptin
resistant state in obesity.
Supporting Information
Figure S1 Normalisation of Ob-R shedding to Ob-R
protein expression in whole cell lysates. sOb-R levels in the
supernatant of Ob-R transfected HEK cells were normalized to
Ob-R-isoform specific protein expression in whole cell lysates.
(DOC)
Figure S2 Metalloproteases are involved in Ob-R shed-
ding. sOb-R levels in the supernatant of Ob-R219.3 transfected
HEK cells after incubation with GM6001 (25–100 mM) for 24 h
and 48 h. sOb-R levels of GM6001-treated cells are displayed
relative to those of non-treated cells. Data are presented as means
6 SD of n$3 experiments.
(DOC)
Figure S3 Metalloproteases ADAM10 and ADAM17 are
involved in PKC activated Ob-R shedding. sOb-R levels in
the supernatant of Ob-R219.3 transfected HEK cells that were
pre-treated for 30 min with GI/GW (3 mM) and further incubated
for 24 h without or with PMA (10 ng/ml). sOb-R levels of PMA-
treated cells are displayed relative to those of non-treated cells.
Data are presented as means 6 SD of n$3 experiments.
(DOC)
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apoptosis with staurosporine. (A) Western blot of Histon H3
in cytoplasmic fraction of HEK cells after staurosporine
incubation. Ob-R transfected HEK cells were incubated with
staurosporine (0.1–0.5 mM) for 24/48 h. Following this incubation
Histon H3 was determined by western Blot analysis in the
cytoplasmic fraction after subcellular fractionation. (B) Relative
amount of nucleosomes in cell supernatants and cytoplasmic
fraction after staurosporine incubation. Ob-R transfected HEK
cells were incubated with 0.5 mM staurosporine for 24/48 h.
Following this incubation nucleosome release was determined by
Cell Death ELISA
PLUS (Roche) in cell supernatants and in the
cytoplasmic fraction according to the instructions of the manu-
facturer. The amount of nucleosomes is displayed relative to
nucleosome levels of non-treated cells. Data are presented as
means 6 SD of n=3 experiments.
(DOC)
Figure S5 Doxorubicin induced Ob-R shedding. (A)
Representative western blot of cleaved PARP after doxorubicin
incubation. Ob-R transfected cells were incubated with doxoru-
bicin (100–500 ng/ml) for 48 h. Following this incubation cleaved
PARP in cell lysates was determined by western Blot analysis. (B)
sOb-R levels in the supernatant of Ob-Rfl or Ob-R219.3
transfected cells after incubation with 500 ng/ml doxorubicin for
24/48 h. sOb-R levels of doxorubicin-treated cells are displayed
relative to sOb-R levels of non-treated cells normalized to total
protein content. Data are presented as means 6 SD of n$3
experiments.
(DOC)
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